Vitamin K Fracture Risk Meta-analysis: What the Evidence Says

Vitamin K Fracture Risk Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are s

3 min read · 586 wordsReviewed August 2026
A child's foot in a cast next to a pile of scattered pills on a white floor. - Evidence evidence guide for vitamin K fracture risk meta-analysis
Photo by cottonbro studio on Pexels · Pexels License

Quick Answer

Vitamin K Fracture Risk Meta analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence aware guidance rather than medical advice.

Key Takeaways

  • 01This page is generated only from sources stored in the Migaku evidence knowledge base.
  • 02Current evidence mix: 1 systematic review, 1 preclinical study.
  • 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • 04This article is educational and does not replace care from a qualified clinician.

Vitamin K Fracture Risk Meta-analysis: What the Evidence Says

Quick Answer

Vitamin K Fracture Risk Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

  • This page is generated only from sources stored in the Migaku evidence knowledge base.
  • Current evidence mix: 1 systematic review, 1 preclinical study.
  • Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • This article is educational and does not replace care from a qualified clinician.

Evidence Map

Source Evidence type Level Date Identifier
Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis systematic review 1 2026-01-01 10.1136/bmj-2025-088050
Polypharmacy and Bone Health in Patients with Type 2 Diabetes Mellitus: A Narrative Review preclinical study 4 2026-05-01 10.11005/jbm.25.975

What The Sources Report

  • Secondary outcomes included the risk of hip fracture, non-vertebral fracture, vertebral fracture, and falling, as well as the total number of falls. [Massé Olivier (2026); evidence level 1]
  • If unpublished data, not obtained through personal communications, were found in another systematic review, we used that review to complete data extraction. [Massé Olivier (2026); evidence level 1]
  • Fracture is a common complication of DM, especially those with longer diabetes duration, vascular complications, and due to the use of specific medications. BMD is a usual significant indicator of bone health and a primary predictor of fracture risk. [Kashmoola Israa O. (2026); evidence level 4]
  • A low BMD means weaker bones and is often indicative of osteoporosis. Evidence stares that T2DM patients routinely reveal average or augmented BMD levels compared to those with type 1 DM (T1DM) or those without T2DM; nevertheless, they experience inappropriate risk of fractures. [Kashmoola Israa O. (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For vitamin K fracture risk meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.

FAQ

Frequently Asked Questions

M

Medically reviewed

Last reviewed August 6, 2026 by Migaku Evidence Review

Related content

← All GuidesSupplement Reference →